




Searching News Database: Biolimus
HSMN NewsFeed - 9 Mar 2012
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
HSMN NewsFeed - 19 Mar 2009
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
HSMN NewsFeed - 27 Dec 2007
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Additional items found! 10

Members Archive contains
10 additional stories matching:
Biolimus
(Password required)
Biolimus
(Password required)